GENE ONLINE|News &
Opinion
Blog

R&D
R&D
Polivy – A New and Improved Arsenal from Roche to Fight DLBCL Relapse
2020-01-24
Trials & Approvals Neurodegenerative Disease
Biogen’s BIIB059 May End a 10-Year Drought with New Lupus Drug
2019-12-18
Trials & Approvals Cancer
FoundationOne®CDx Approved as Companion Diagnostic for Novartis’ Piqray
2019-12-09
R&D Clostridium
Combating Clostridium difficile infections using Fecal Microbiota Transplant
2019-12-02
R&D Aging
Regenerative Medicine provides Answer to Aging: ICare Global Health Biotech’s SRF Technology Aims to Treat Arthritis in the Elderly
2019-12-02
R&D GalNAC
Novo Nordisk Becomes Dicerna’s Fifth Big Pharma Partnership
2019-11-19
In-Depth Depression
SECUADO – The Hope to Enhance Schizophrenia Patients’ Quality of Life
2019-11-14
R&D
Unveiling of KRAS Inhibitor Clinical Data Initiates Mirati, Amgen comparisons
2019-10-29
R&D
Meru Reports Proof of Concept for Its Bispecific Antibody in NRG1 Fusion Cancers
2019-10-29
R&D
Gene Editing Companies to Exchange Patented Tech to Develop Cancer Therapies
2019-10-28
R&D Alzheimer's Disease
Biogen Stock Soars Following U-turn with their Alzheimer Drug Plans
2019-10-22
R&D Anti-fibrotic
Boehringer Ingelheim’s New Drug – Nintedanib – Lowers Pulmonary Fibrosis by 57%
2019-10-21
R&D Asthma
Astra Zeneca to Resume Rivalry with Old Competitor Following Key Win for FASENRA®
2019-10-14
R&D Oxygen
Discovery of cellular mechanisms for oxygen sensing earns prestigious Nobel for 2019
2019-10-07
Trials & Approvals Asthma
Novartis Reports Trial Successes of its Asthma Drugs that Holds Potential Edge Over Longstanding Market Leader
2019-10-04
1 … 30 31 32 33 34
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top